Home
About Acrux
Acrux History
Board of Directors
Management Team
Our Values
Partnering with us
What We Do
Research & Development
Generic Product Development
Speciality Topical Drug Delivery
Product Pipeline
Products
Lidocaine and Prilocaine Cream, USP 2.5%/2.5%
LENZETTO
®
EVAMIST
®
Dapsone5%, Gel
Partnering With Us
Partnerships
Facilities & Capabilities
Investor Centre
Investor Fact Sheet
Corporate Governance
Announcements & Reports
Share Price Information
Shareholder Services
Email Alerts
Event Calendar
Careers
Contact Us
Search
Don Brumley, appointed June 2021
June 4, 2021
By
acrux
